Krähenbühl Jean-Marc, Kremer Bertha, Guignard Bertrand, Bugnon Olivier
Ambulatory Care and Community Medicine Department, Community Pharmacy Unit, Rue du Bugnon 44, 1011 Lausanne, Switzerland.
Pharm World Sci. 2008 Dec;30(6):777-86. doi: 10.1007/s11096-008-9217-4. Epub 2008 Apr 6.
To develop and evaluate a coding system integrated into pharmaceutical software to routinely report and assess the process of community pharmacists' interventions related to medical prescriptions.
A convenient sample of 20 Swiss community pharmacies.
Pharmacists documented their interventions concerning all drug-related problems (DRPs) related to medical prescriptions during four consecutive weeks in 2005. The coding system assesses each step of the DRP management process; that is, the type of problem, possible negative outcomes, pharmaceutical decisions, and individuals involved. In order to be comprehensive, the management process of technical problems related to prescriptions and clinical DRPs was analysed separately.
DRP intervention rate and characterization of each step of the process.
Of 38,663 prescriptions, 287 clinical DRPs required interventions. This corresponds to a mean intervention rate of 0.77% per pharmacy (SD = 0.61%). There was a large variability among pharmacies (0-2.6%). Most of the clinical DRPs were associated with dosage problems (n = 91) and drug-drug interactions (n = 45). The most frequent potential negative outcomes reported were quantitative inefficacy (n = 101) and quantitative safety (n = 94). Two-thirds of clinical DRPs required a prescription modification (n = 186), the most frequent being a change in dosage or drug regimen. In 110 interventions (38%), physicians were immediately contacted to take part in the decision. In 122 interventions (43%), pharmacists managed the interventions alone. However, in 55 interventions (19%), pharmacists managed the DRPs with the patient. From these 287 clinical interventions, 134 different codes were reported. Seven hundred and thirty-six technical problems related to prescriptions required intervention, which corresponded to a mean intervention rate of 1.90% per pharmacy. The main type of problem was a discrepancy with the medication record (n = 208). There were 494 instances that required a prescription modification. Pharmacists resolved 45% of all technical problems by themselves.
The developed coding system could describe the management process for DRPs. The observed intervention rate and the frequency of steps involved were comparable to those previously observed for pharmacists' interventions. Data regarding the entire process used to manage drug-related problems can be useful in improving medication safety, education, and collaborative care.
开发并评估一种集成于药学软件的编码系统,以常规报告和评估社区药师与医疗处方相关干预措施的过程。
选取20家瑞士社区药房作为便利样本。
药师记录了2005年连续四周内他们针对所有与医疗处方相关的药物相关问题(DRP)所采取的干预措施。该编码系统评估DRP管理过程的每一步;即问题类型、可能的负面结果、药学决策以及涉及的人员。为全面起见,分别分析了与处方相关的技术问题和临床DRP的管理过程。
DRP干预率及过程中每一步的特征。
在38663张处方中,287个临床DRP需要干预。这相当于每家药房的平均干预率为0.77%(标准差 = 0.61%)。各药房之间存在很大差异(0 - 2.6%)。大多数临床DRP与剂量问题(n = 91)和药物相互作用(n = 45)有关。报告的最常见潜在负面结果是定量无效(n = 101)和定量安全(n = 94)。三分之二的临床DRP需要修改处方(n = 186),最常见的是剂量或用药方案的改变。在110次干预(38%)中,立即联系医生参与决策。在122次干预(43%)中,药师独自管理干预措施。然而,在55次干预(19%)中,药师与患者共同管理DRP。从这287次临床干预中,报告了134个不同的代码。736个与处方相关的技术问题需要干预,这相当于每家药房的平均干预率为1.90%。主要问题类型是与用药记录不符(n = 208)。有494例需要修改处方。药师自行解决了所有技术问题的45%。
所开发的编码系统能够描述DRP的管理过程。观察到的干预率和所涉及步骤的频率与之前观察到的药师干预情况相当。有关管理药物相关问题的整个过程的数据有助于提高用药安全性、教育水平和协作护理。